STOCK TITAN
  1. Home
  2. Sec-filings
  3. ENVX
  4. [Form 4] Enovix Corp Insider Trading Activity

Enovix (ENVX) director receives 29,104 RSUs held for Eclipse Ventures

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
4

Rhea-AI Filing Summary

Enovix Corp director Gregory Reichow reported an equity grant of 29,104 restricted stock units (RSUs) with no cash exercise price. Each RSU represents one share of common stock, and this award brings his reported holdings, including RSUs, to 87,385 shares.

The RSUs vest in four equal installments of 25% on September 11, 2026, December 11, 2026, March 11, 2027, and the earlier of June 11, 2027 or the company’s 2027 annual stockholder meeting, subject to continued service. Under an agreement with Eclipse Ventures, LLC, the RSUs are held for Eclipse’s benefit, and Reichow disclaims beneficial ownership beyond any pecuniary interest.

Positive

  • None.

Negative

  • None.
Insider Reichow Gregory
Role null
Type Security Shares Price Value
Grant/Award Common Stock 29,104 $0.00 --
Holdings After Transaction: Common Stock — 87,385 shares (Direct, null)
Footnotes (1)
  1. Reflects shares issuable on the settlement of restricted stock units ("RSUs") granted to the Reporting Person. Each RSU represents a contingent right to receive one share of the Issuer's common stock. 25% of the RSUs will vest on each of September 11, 2026, December 11, 2026, March 11, 2027 and the earlier of (i) June 11, 2027; or (ii) the date of the Issuer's 2027 annual meeting of stockholders (or the date immediately preceding such date if the Reporting Person's service as a director ends at such meeting due to the director's failure to be re-elected or not standing for re-election), subject to the Reporting Person's continuous service through each applicable vesting date. Includes 29,104 shares issuable upon the settlement of RSUs granted to the Reporting Person. Pursuant to the Eclipse GP III, LLC Agreement, the Reporting Person is deemed to hold the RSUs for the benefit of Eclipse Ventures, LLC ("Eclipse"), which is entitled to hold the shares upon settlement of the RSUs. Eclipse may be deemed the indirect beneficial owner of such shares, and the Reporting Person is a partner of and may be deemed to share voting and dispositive power over shares held by Eclipse. The Reporting Person disclaims beneficial ownership of such shares except to the extent of any pecuniary interest therein.
RSU grant size 29,104 RSUs Restricted stock units granted to reporting person
Grant price $0.00 per share Reported transaction price for RSU award
Post-transaction holdings 87,385 shares Shares reported following RSU grant, including issuable RSUs
First vesting date September 11, 2026 25% of RSUs vest
Second vesting date December 11, 2026 Additional 25% of RSUs vest
Third vesting date March 11, 2027 Additional 25% of RSUs vest
Final vesting date June 11, 2027 or 2027 meeting Remaining 25% of RSUs vest, subject to conditions
restricted stock units ("RSUs") financial
"Reflects shares issuable on the settlement of restricted stock units ("RSUs") granted to the Reporting Person."
Restricted stock units (RSUs) are a company promise to give an employee shares of stock (or cash equivalent) in the future, but only after certain conditions—usually staying with the company for a set time or hitting performance goals—are met. Investors watch RSUs because when they vest they increase the number of shares outstanding and can lead insiders to sell shares, affecting share price, company dilution and the true cost of employee pay.
beneficial owner financial
"Eclipse may be deemed the indirect beneficial owner of such shares, and the Reporting Person disclaims beneficial ownership of such shares..."
A beneficial owner is the person who ultimately owns or controls a financial asset or property, even if their name isn't directly on official documents. Think of it like someone who secretly holds the keys to a safe deposit box—others may appear to have access, but the true owner is the one who benefits from what's inside. Identifying beneficial owners helps ensure transparency and prevent illegal activities like money laundering or fraud.
pecuniary interest financial
"The Reporting Person disclaims beneficial ownership of such shares except to the extent of any pecuniary interest therein."
voting and dispositive power financial
"the Reporting Person is a partner of and may be deemed to share voting and dispositive power over shares held by Eclipse."
See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google
Form 4 Insider Transactions: What Each Field Means →
SEC Form 4
FORM 4UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number:3235-0287
Estimated average burden
hours per response:0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
Reichow Gregory
(Last)(First)(Middle)
C/O ENOVIX CORPORATION
3501 W. WARREN AVENUE
(Street)
FREMONT CALIFORNIA 94538
(City)(State)(Zip)
UNITED STATES
(Country)		2. Issuer Name and Ticker or Trading Symbol
Enovix Corp [ ENVX ] 		5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
XDirector10% Owner
Officer (give title below)Other (specify below)
2a. Foreign Trading Symbol
3. Date of Earliest Transaction (Month/Day/Year)
06/11/2026		6. Individual or Joint/Group Filing (Check Applicable Line)
XForm filed by One Reporting Person
Form filed by More than One Reporting Person
4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year)2A. Deemed Execution Date, if any (Month/Day/Year)3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeVAmount(A) or (D)Price
Common Stock06/11/2026A29,104(1)A$087,385(2)D(3)
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year)3A. Deemed Execution Date, if any (Month/Day/Year)4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year)7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeV(A)(D)Date ExercisableExpiration DateTitleAmount or Number of Shares
Explanation of Responses:
1. Reflects shares issuable on the settlement of restricted stock units ("RSUs") granted to the Reporting Person. Each RSU represents a contingent right to receive one share of the Issuer's common stock. 25% of the RSUs will vest on each of September 11, 2026, December 11, 2026, March 11, 2027 and the earlier of (i) June 11, 2027; or (ii) the date of the Issuer's 2027 annual meeting of stockholders (or the date immediately preceding such date if the Reporting Person's service as a director ends at such meeting due to the director's failure to be re-elected or not standing for re-election), subject to the Reporting Person's continuous service through each applicable vesting date.
2. Includes 29,104 shares issuable upon the settlement of RSUs granted to the Reporting Person.
3. Pursuant to the Eclipse GP III, LLC Agreement, the Reporting Person is deemed to hold the RSUs for the benefit of Eclipse Ventures, LLC ("Eclipse"), which is entitled to hold the shares upon settlement of the RSUs. Eclipse may be deemed the indirect beneficial owner of such shares, and the Reporting Person is a partner of and may be deemed to share voting and dispositive power over shares held by Eclipse. The Reporting Person disclaims beneficial ownership of such shares except to the extent of any pecuniary interest therein.
Remarks:
/s/ Arthi Chakravarthy, Attorney-in-Fact for Gregory Reichow06/15/2026
** Signature of Reporting PersonDate
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)

Source: View Original Filing on SEC EDGAR

FAQ

What did Enovix (ENVX) director Gregory Reichow report in this Form 4?

Gregory Reichow reported receiving 29,104 restricted stock units (RSUs) of Enovix common stock as an equity award. The grant carries a zero dollar price per share and is structured as stock-based compensation rather than a cash purchase in the open market.

How many Enovix (ENVX) shares does Gregory Reichow report holding after this transaction?

After the RSU grant, Gregory Reichow reports 87,385 Enovix shares, including shares issuable on RSU settlement. This total reflects his direct reported position tied to this award and prior holdings, as disclosed in the Form 4’s post-transaction share figure.

What is the vesting schedule for Gregory Reichow’s Enovix (ENVX) RSU grant?

The 29,104 Enovix RSUs vest in four equal 25% installments. Vesting dates are September 11, 2026, December 11, 2026, March 11, 2027, and the earlier of June 11, 2027 or the 2027 annual stockholder meeting, contingent on continued service.

Does Gregory Reichow personally pay for the Enovix (ENVX) RSUs granted?

No, the Enovix RSUs were granted at a reported price of $0.00 per unit. This indicates a compensation award rather than a purchase, giving Reichow a contingent right to receive common shares upon future vesting and settlement of the RSUs.

Who is the beneficial owner of the Enovix (ENVX) RSUs associated with Gregory Reichow?

The RSUs are deemed held for the benefit of Eclipse Ventures, LLC under the Eclipse GP III, LLC Agreement. Eclipse may be considered the indirect beneficial owner, while Reichow disclaims beneficial ownership except for any pecuniary interest in those shares.

Are Gregory Reichow’s Enovix (ENVX) RSUs subject to any service condition?

Yes, vesting of the Enovix RSUs requires continuous service through each vesting date. If his service as a director ends at the 2027 annual meeting under specified conditions, the final installment vests on the date immediately preceding that meeting instead of June 11, 2027.